Error: Could not add to watchlist. X
+ Watchlist

Keryx Biopharmaceuticals Inc

KERX:US
NASDAQ CM
6.50
USD
0.04
0.62%
As of 10/20/2017
Open
6.54
Day Range
6.39 - 6.60
Volume
996,161
Previous Close
6.46
52Wk Range
4.11 - 8.38
1 Yr Return
38.59%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
6.54
Day Range
6.39 - 6.60
Volume
996,161
Previous Close
6.46
52Wk Range
4.11 - 8.38
1 Yr Return
38.59%
YTD Return
10.92%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.69
Market Cap (m USD)
771.877
Shares Outstanding (m)
118.750
Price/Sales (TTM)
16.47
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
-0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.
Address
One Marina Park Drive
Twelfth Floor
Boston, MA 02210
United States
Phone
1-617-466-3500
Show More